AmorChem

AmorChem is an early-stage venture fund that turns academic research into new biotech companies. It has been active since 2011 and aims to become the main early-stage fund of its kind in Canada. The firm looks closely at the science behind each project rather than only the business plan.

What AmorChem offers

• Research funding — has financed over 30 academic research programmes.
• Company creation — helps establish biotech businesses around promising therapeutic ideas.
• Translational focus — invests in the research needed to bridge the gap between discovery and a viable company.
• Community building — aims to grow a collaborative group of biotech start-ups and science entrepreneurs.

Who it works with

The fund works with university researchers and scientist-entrepreneurs in Canada. Its social posts mention NuChem, a company it helped create, and Find Therapeutics.

Key facts

• Region: Canada
• Active since: 2011
• Programmes financed: more than 30